What are the NCCN colonoscopy screening and surveillance guidelines for average‑risk adults, individuals with a family history of colorectal cancer, prior adenomas or serrated polyps, inflammatory bowel disease, or hereditary colorectal cancer syndromes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

NCCN Colonoscopy Screening and Surveillance Guidelines

Average-Risk Adults

For average-risk adults, NCCN recommends beginning colorectal cancer screening at age 45 years and continuing through age 75 years, with colonoscopy every 10 years as a primary screening option. 1

Screening Initiation and Age Range

  • Begin screening at age 45 years for adults with no personal history of adenoma, sessile serrated lesions (SSLs), CRC, inflammatory bowel disease, high-risk genetic syndromes, cystic fibrosis, or childhood cancer, and no family history of CRC or advanced adenomas 1
  • Continue screening through age 75 years as the standard recommendation 1
  • For ages 76-85 years, screening decisions should be individualized based on prior screening history, comorbidity status, and estimated life expectancy, with those who have never been screened most likely to benefit 1
  • Do not screen adults older than 85 years 1

Screening Modality Options for Average-Risk Adults

NCCN provides multiple acceptable screening options 1:

Colonoscopy:

  • Every 10 years 1
  • If incomplete or preparation is suboptimal, consider alternative screening modality or repeat colonoscopy within 1 year 1

Stool-Based Tests:

  • High-sensitivity guaiac-based or immunochemical-based testing (FIT) annually, with FIT showing superior sensitivity to guaiac-based tests 1
  • FIT-DNA testing every 3 years 1

Structural Tests:

  • Flexible sigmoidoscopy every 5-10 years 1
  • CT colonography (CTC) every 5 years 1

Important Caveats for Average-Risk Screening

  • Any abnormal result from stool-based screening tests is an indication for colonoscopy 1
  • A blood test detecting circulating methylated SEPT9 DNA is FDA-approved but has inferior ability to detect CRC and advanced adenoma compared to other recommended modalities 1
  • NCCN does not currently endorse screening with barium enema 1

Increased-Risk Adults: Family History of Colorectal Cancer

First-Degree Relative with CRC Diagnosed <60 Years

  • Begin colonoscopy at age 40 years OR 10 years before the age at diagnosis of the affected relative, whichever comes first 2, 3
  • Repeat colonoscopy every 5 years 2, 3, 4
  • This recommendation applies because the risk is 3-4 times higher than average-risk populations 2, 4

Two or More First-Degree Relatives with CRC at Any Age

  • Begin colonoscopy at age 40 years OR 10 years before the youngest affected relative's diagnosis, whichever is earlier 2, 3
  • Repeat colonoscopy every 5 years 2, 3

First-Degree Relative with CRC Diagnosed ≥60 Years

  • Begin screening at age 40 years using average-risk screening options (colonoscopy every 10 years or annual FIT) 2, 3
  • The risk is only modestly elevated (1.8-1.9 fold) in this scenario 3

First-Degree Relative with Advanced Adenoma Diagnosed <60 Years

  • Follow the same protocol as CRC diagnosed <60 years: colonoscopy at age 40 years or 10 years before diagnosis, repeated every 5 years 2, 3

Second- or Third-Degree Relatives with CRC

  • Begin colonoscopy at age 45 years and repeat every 10 years 2, 3

Critical Verification Required

  • Always verify the exact age at diagnosis of affected relatives, as the 60-year cutoff determines whether 5-year or 10-year intervals are recommended 2, 3
  • Family history information is often incomplete or inaccurate—confirm the diagnosis and relationship whenever possible 3, 5

Post-Polypectomy Surveillance

After Removal of Adenomatous Polyps

For 1-2 Small (<1 cm) Tubular Adenomas with Low-Grade Dysplasia:

  • Next colonoscopy in 5-10 years, with timing based on family history and other clinical factors 3

For Advanced Adenomas (≥1 cm, villous features, high-grade dysplasia) OR 3-10 Total Adenomas:

  • Next colonoscopy in 3 years 3
  • If the 3-year surveillance is clear or shows only 1-2 small tubular adenomas, the interval can be extended to 5 years for subsequent colonoscopies 3
  • If the 3-year surveillance shows 3+ adenomas or any advanced features, continue 3-year intervals 3

For Piecemeal Removal:

  • A 2-6 month follow-up colonoscopy is necessary to verify complete removal before establishing the surveillance schedule 3

Inflammatory Bowel Disease

While NCCN guidelines focus primarily on sporadic CRC screening, patients with long-standing inflammatory bowel disease require specialized surveillance protocols beyond average-risk screening 1. These patients are considered above-average risk and require colonoscopy-based surveillance rather than stool-based screening 1.


Hereditary Colorectal Cancer Syndromes

Classical Familial Adenomatous Polyposis (FAP)

When Mutation is Known in Family:

  • APC gene testing for at-risk first-degree relatives 1
  • If APC gene positive: flexible sigmoidoscopy or colonoscopy every 12 months beginning at age 10-15 years 1
  • If APC gene negative: follow average-risk screening 1

When Mutation is Unknown in Family:

  • APC gene testing of affected family member first 1
  • If affected family member unavailable: flexible sigmoidoscopy or colonoscopy beginning at age 10-15 years with the following schedule 1:
    • Every 12 months until age 24 years
    • Every 2 years until age 34 years
    • Every 3 years until age 44 years
    • Then every 3-5 years thereafter
  • Consider substituting colonoscopy every 5 years beginning at age 20 years for the possibility of attenuated FAP 1
  • Consider MYH testing when polyposis is present with negative APC testing 1

Lynch Syndrome Suspicion

  • Multiple relatives with polyps or cancer, especially if diagnosed before age 50, should prompt genetic counseling 3
  • If Lynch syndrome is confirmed: colonoscopy every 1-2 years starting 10 years before the youngest affected relative's diagnosis age 3

Common Pitfalls to Avoid

  • Do not wait until age 50 to begin screening if any first-degree relative has CRC—screening must start at age 40 at the latest 3, 5
  • Do not use 10-year intervals for colonoscopy if a first-degree relative was diagnosed before age 60 or if there are two or more affected first-degree relatives—these situations require 5-year intervals 3
  • Do not assume all family history is equal—second-degree relatives do not warrant the same intensive screening as first-degree relatives 3
  • Single-panel guaiac FOBT performed in the office during digital rectal examination is NOT acceptable for screening due to very low sensitivity 5
  • All stool-based tests should be done on voided stool samples, not on samples obtained by digital rectal examination 1

Quality Indicators for Colonoscopy

Colonoscopy quality is critical for effective screening 1, 5:

  • Cecal intubation rate should be achieved 1, 5
  • Adenoma detection rate ≥25% in men 5
  • Withdrawal time ≥6 minutes 5
  • Adequate bowel preparation is essential and should be discussed with patients 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Colorectal Cancer Screening Recommendations for Average‑Risk and High‑Risk Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Colonoscopy Surveillance Frequency for Individuals with Strong Family History and Non-Cancerous Polyps

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Indications for Colonoscopy in Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the recommended age to start colonoscopy (colon examination using a flexible tube with a camera) screening for an average-risk individual with no personal or family history of colorectal cancer or polyps?
At what age should colonoscopy screening begin for average‑risk adults and for individuals with a first‑degree relative with colorectal cancer or advanced adenoma, multiple affected relatives, or inflammatory bowel disease?
What are the recommended methods and timing for colorectal cancer screening?
At what age should an asymptomatic individual with no personal or family history of colorectal cancer (CRC) and average risk start colonoscopy screening?
At what age should a 38-year-old woman with no medical history or family history of cancer start screening for colon cancer?
Should a 67-year-old athletic male be concerned about a 15% supraventricular tachycardia (SVT) burden?
I am experiencing tremor after starting olanzapine; how should it be evaluated and managed?
In an adult with obstructive sleep apnea who is adherent to CPAP (>4 hours/night on ≥70 % of nights) but still has persistent excessive daytime sleepiness or fatigue, is modafinil indicated?
In an asymptomatic patient with hyperuricemia (serum uric acid 443 µmol/L ≈7.5 mg/dL) and no risk factors, should febuxostat be initiated?
What is the recommended intravenous fosfomycin dosing regimen for severe adult infections, and how should the dose be adjusted in patients with impaired renal function?
In an adolescent with stage II–III colon adenocarcinoma, is radiation therapy indicated as part of treatment?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.